Overview
- 39 inspections across 39 sites are on record.
- 107 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-04-05.
At a glance
Inspections
39
Sites
39
Observations
107
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Emcure Pharmaceuticals Limited | 5 Apr 2024 | Human Drugs | View 483 → |
| ONESOURCE SPECIALTY PHARMA LIMITED | 28 Mar 2024 | Human Drugs | View 483 → |
| Laboratorio Reig Jofre Sa. | 23 Jun 2023 | Human Drugs | View 483 → |
| STERISCIENCE SP Z O O | 28 Apr 2023 | Human Drugs | View 483 → |
| Solvias AG | 22 Nov 2022 | Human Drugs | View 483 → |
Sites inspected
Emcure Pharmaceuticals LimitedAhmedabad, India1 insp.
ONESOURCE SPECIALTY PHARMA LIMITEDBengaluru, India1 insp.
Laboratorio Reig Jofre Sa.Toledo, Spain1 insp.
STERISCIENCE SP Z O OWarsaw, Poland1 insp.
Solvias AGKaiseraugst, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Michele Perry Williams5 shared
Jose A Cruz Gonzalez4 shared
Michele Perry-Williams3 shared
Guerlain Ulysse2 shared
Arie Menachem2 shared
Francis A Guidry2 shared
Libia M Lugo2 shared
Katherine E Jacobitz2 shared
Seneca D Toms2 shared
Charisse K Green2 shared
Full investigator report
Get the verbatim findings behind Xiaokuang Lai's 107 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site